中国肺癌筛查与早诊早治指南(2021,北京)

2021-03-30 国家癌症中心 中华肿瘤杂志.2021.43(3):243-268.

肺癌是中国发病率和死亡率最高的恶性肿瘤。筛查与早诊早治是降低人群肺癌死亡率的有效措施。制定符合中国国情的肺癌筛查与早诊早治指南,将极大推进中国肺癌筛查的同质性和优质性,提高肺癌筛查的效果。指南受国家卫

中文标题:

中国肺癌筛查与早诊早治指南(2021,北京)

发布机构:

国家癌症中心

发布日期:

2021-03-30

简要介绍:

肺癌是中国发病率和死亡率最高的恶性肿瘤。筛查与早诊早治是降低人群肺癌死亡率的有效措施。制定符合中国国情的肺癌筛查与早诊早治指南,将极大推进中国肺癌筛查的同质性和优质性,提高肺癌筛查的效果。指南受国家卫生健康委员会疾病预防控制局委托与指导,由国家癌症中心发起,联合多学科专家共同制定。指南整合近年来国内外在肺癌筛查与早诊早治方面的新进展,同时考虑中国国情和肺癌筛查的实际经验,根据世界卫生组织指南制定手册的原则和方法,针对肺癌筛查过程中的筛查人群、技术、流程等给出了详细的循证推荐,旨在规范肺癌筛查与早诊早治实践,提升中国肺癌防控效果。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=中国肺癌筛查与早诊早治指南(2021,北京).pdf)] GetToolGuiderByIdResponse(projectId=1, id=146551c0020861f1, title=中国肺癌筛查与早诊早治指南(2021,北京), enTitle=, guiderFrom=中华肿瘤杂志.2021.43(3):243-268., authorId=0, author=, summary=肺癌是中国发病率和死亡率最高的恶性肿瘤。筛查与早诊早治是降低人群肺癌死亡率的有效措施。制定符合中国国情的肺癌筛查与早诊早治指南,将极大推进中国肺癌筛查的同质性和优质性,提高肺癌筛查的效果。指南受国家卫, cover=https://img.medsci.cn/2021423/1619189602232_2020535.jpg, journalId=0, articlesId=null, associationId=1931, associationName=国家癌症中心, associationIntro=国家癌症中心, copyright=0, guiderPublishedTime=Tue Mar 30 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>肺癌是中国发病率和死亡率最高的恶性肿瘤。筛查与早诊早治是降低人群肺癌死亡率的有效措施。制定符合中国国情的肺癌筛查与早诊早治指南,将极大推进中国肺癌筛查的同质性和优质性,提高肺癌筛查的效果。指南受国家卫生健康委员会疾病预防控制局委托与指导,由国家癌症中心发起,联合多学科专家共同制定。指南整合近年来国内外在肺癌筛查与早诊早治方面的新进展,同时考虑中国国情和肺癌筛查的实际经验,根据世界卫生组织指南制定手册的原则和方法,针对肺癌筛查过程中的筛查人群、技术、流程等给出了详细的循证推荐,旨在规范肺癌筛查与早诊早治实践,提升中国肺癌防控效果。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=2809, tagName=肺癌筛查)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=2809, guiderKeyword=肺癌筛查, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6834, appHits=434, showAppHits=0, pcHits=1265, showPcHits=6398, likes=7, shares=36, comments=34, approvalStatus=1, publishedTime=Fri Apr 23 23:07:59 CST 2021, publishedTimeString=2021-03-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Fri Apr 23 22:53:28 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 22:40:06 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=中国肺癌筛查与早诊早治指南(2021,北京).pdf)])
中国肺癌筛查与早诊早治指南(2021,北京).pdf
下载请点击:
评论区 (27)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2089541, encodeId=d22e2089541df, content=学习一下!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c65519018, createdName=ms9000001667164013, createdTime=Wed Sep 21 14:25:37 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208585, encodeId=e01d1208585a9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=00ec8098175, createdName=ms3000000771933475, createdTime=Mon Apr 04 18:49:21 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071742, encodeId=764110e17423b, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce275198839, createdName=14735162m04(暂无昵称), createdTime=Fri Nov 19 12:58:22 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069111, encodeId=f53f106911163, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Wed Nov 10 22:44:32 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057416, encodeId=a4a3105e416a5, content=太有用了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f72b1400629, createdName=shirly.li19560809, createdTime=Mon Oct 04 09:29:56 CST 2021, time=2021-10-04, status=1, ipAttribution=)]
    2022-09-21 ms9000001667164013

    学习一下!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2089541, encodeId=d22e2089541df, content=学习一下!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c65519018, createdName=ms9000001667164013, createdTime=Wed Sep 21 14:25:37 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208585, encodeId=e01d1208585a9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=00ec8098175, createdName=ms3000000771933475, createdTime=Mon Apr 04 18:49:21 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071742, encodeId=764110e17423b, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce275198839, createdName=14735162m04(暂无昵称), createdTime=Fri Nov 19 12:58:22 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069111, encodeId=f53f106911163, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Wed Nov 10 22:44:32 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057416, encodeId=a4a3105e416a5, content=太有用了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f72b1400629, createdName=shirly.li19560809, createdTime=Mon Oct 04 09:29:56 CST 2021, time=2021-10-04, status=1, ipAttribution=)]
    2022-04-04 ms3000000771933475

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2089541, encodeId=d22e2089541df, content=学习一下!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c65519018, createdName=ms9000001667164013, createdTime=Wed Sep 21 14:25:37 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208585, encodeId=e01d1208585a9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=00ec8098175, createdName=ms3000000771933475, createdTime=Mon Apr 04 18:49:21 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071742, encodeId=764110e17423b, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce275198839, createdName=14735162m04(暂无昵称), createdTime=Fri Nov 19 12:58:22 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069111, encodeId=f53f106911163, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Wed Nov 10 22:44:32 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057416, encodeId=a4a3105e416a5, content=太有用了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f72b1400629, createdName=shirly.li19560809, createdTime=Mon Oct 04 09:29:56 CST 2021, time=2021-10-04, status=1, ipAttribution=)]
    2021-11-19 14735162m04(暂无昵称)

    谢谢

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2089541, encodeId=d22e2089541df, content=学习一下!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c65519018, createdName=ms9000001667164013, createdTime=Wed Sep 21 14:25:37 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208585, encodeId=e01d1208585a9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=00ec8098175, createdName=ms3000000771933475, createdTime=Mon Apr 04 18:49:21 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071742, encodeId=764110e17423b, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce275198839, createdName=14735162m04(暂无昵称), createdTime=Fri Nov 19 12:58:22 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069111, encodeId=f53f106911163, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Wed Nov 10 22:44:32 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057416, encodeId=a4a3105e416a5, content=太有用了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f72b1400629, createdName=shirly.li19560809, createdTime=Mon Oct 04 09:29:56 CST 2021, time=2021-10-04, status=1, ipAttribution=)]
    2021-11-10 未来将来

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2089541, encodeId=d22e2089541df, content=学习一下!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6c65519018, createdName=ms9000001667164013, createdTime=Wed Sep 21 14:25:37 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208585, encodeId=e01d1208585a9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=00ec8098175, createdName=ms3000000771933475, createdTime=Mon Apr 04 18:49:21 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071742, encodeId=764110e17423b, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce275198839, createdName=14735162m04(暂无昵称), createdTime=Fri Nov 19 12:58:22 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069111, encodeId=f53f106911163, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Wed Nov 10 22:44:32 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057416, encodeId=a4a3105e416a5, content=太有用了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f72b1400629, createdName=shirly.li19560809, createdTime=Mon Oct 04 09:29:56 CST 2021, time=2021-10-04, status=1, ipAttribution=)]
    2021-10-04 shirly.li19560809

    太有用了

    0

拓展阅读

中国肺癌低剂量螺旋CT筛查指南(2018年版)

中国肺癌早诊早治专家组 · 2018-02-20

2018 ACR适宜性标准:肺癌筛查

美国放射学会(ACR,American College of Radiology) · 2018-11-05

2020 ESR/ERS声明文件:肺癌的筛查

欧洲放射学会(ESR,European Society of Radiology) · 2020-02-12

中国肺癌筛查标准(T/CPMA 013-2020)

中华预防医学会(CPMA,Chinese Preventive Medicine Association) · 2021-01-28

2021 CHEST指南和专家组报告:肺癌筛查

美国胸科医师学会(ACCP,American College of Chest Physicians) · 2021-11-06

2022 ACR适宜性标准:肺癌筛查(更新版)

美国放射学会(ACR,American College of Radiology) · 2023-05-24